Cathie Wood Intellia Therapeutics, Inc. Transaction History

Ark Investment Management LLC

$9.28 Billion
Q1 2025

A detailed history of Cathie Wood (Ark Investment Management LLC) transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Ark Investment Management LLC holds 13,011,015 shares of NTLA stock, worth $154 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

13,011,015

Previous 12,536,386 3.79%

Holding current value

$154 Million

Previous $146 Million 36.71%

% of portfolio

1.0%

Previous 1.28%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$7.11 - $12.8 $3.37 Million - $6.08 Million	474,629 Added 3.79%	13,011,015 $92.5 Million
Q4 2024 Feb 04, 2025	BUY	$11.41 - $21.09 $3.21 Million - $5.93 Million	280,946 Added 2.29%	12,536,386 $146 Million
Q3 2024 Oct 31, 2024	BUY	$19.72 - $27.36 $13 Million - $18 Million	659,651 Added 5.69%	12,255,440 $252 Million
Q2 2024 Jul 26, 2024	BUY	$20.02 - $27.22 $12.1 Million - $16.5 Million	606,507 Added 5.52%	11,595,789 $260 Million
Q1 2024 Apr 18, 2024	SELL	$23.82 - $32.8 $10.1 Million - $13.9 Million	-423,167 Reduced 3.71%	10,989,282 $302 Million
Q4 2023 Jan 17, 2024	BUY	$23.16 - $32.34 $33.9 Million - $47.3 Million	1,463,820 Added 14.71%	11,412,449 $348 Million
Q3 2023 Oct 18, 2023	BUY	$31.62 - $45.78 $13.4 Million - $19.4 Million	422,698 Added 4.44%	9,948,629 $315 Million
Q2 2023 Jul 10, 2023	SELL	$34.58 - $46.03 $10.8 Million - $14.3 Million	-311,235 Reduced 3.16%	9,525,931 $388 Million
Q1 2023 Apr 17, 2023	BUY	$33.3 - $44.82 $13.9 Million - $18.7 Million	416,384 Added 4.42%	9,837,166 $367 Million
Q4 2022 Jan 24, 2023	SELL	$33.21 - $62.69 $7.85 Million - $14.8 Million	-236,270 Reduced 2.45%	9,420,782 $0
Q3 2022 Oct 17, 2022	BUY	$53.92 - $71.7 $7.68 Million - $10.2 Million	142,472 Added 1.5%	9,657,052 $540 Million
Q2 2022 Jul 11, 2022	BUY	$38.49 - $76.21 $20.5 Million - $40.7 Million	533,551 Added 5.94%	9,514,580 $439 Million
Q1 2022 Apr 19, 2022	BUY	$58.27 - $118.99 $62 Million - $127 Million	1,064,147 Added 13.44%	8,981,029 $653 Million
Q4 2021 Jan 28, 2022	BUY	$100.76 - $138.36 $118 Million - $162 Million	1,173,326 Added 17.4%	7,916,882 $936 Million
Q3 2021 Nov 12, 2021	SELL	$132.37 - $176.78 $125 Million - $166 Million	-940,885 Reduced 12.24%	6,743,556 $905 Million
Q2 2021 Aug 05, 2021	SELL	$60.88 - $161.91 $117 Million - $312 Million	-1,927,470 Reduced 20.05%	7,684,441 $1.24 Billion
Q1 2021 May 13, 2021	SELL	$46.59 - $83.68 $73.6 Million - $132 Million	-1,579,759 Reduced 14.12%	9,611,911 $771 Million
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $4.01 Million - $13.5 Million	-213,082 Reduced 1.87%	11,191,670 $609 Million
Q3 2020 Oct 30, 2020	BUY	$17.47 - $24.93 $23,986 - $34,228	1,373 Added 0.01%	11,404,752 $227 Million
Q2 2020 Aug 11, 2020	BUY	$11.14 - $22.87 $13 Million - $26.6 Million	1,164,093 Added 11.37%	11,403,379 $240 Million
Q1 2020 May 14, 2020	BUY	$9.44 - $15.58 $14.1 Million - $23.3 Million	1,497,854 Added 17.14%	10,239,286 $125 Million
Q4 2019 Jan 31, 2020	BUY	$10.43 - $17.67 $2.83 Million - $4.79 Million	270,856 Added 3.2%	8,741,432 $128 Million
Q3 2019 Nov 12, 2019	BUY	$13.07 - $18.51 $2.97 Million - $4.21 Million	227,411 Added 2.76%	8,470,576 $113 Million
Q2 2019 Jul 30, 2019	BUY	$13.88 - $18.41 $3.64 Million - $4.82 Million	261,967 Added 3.28%	8,243,165 $135 Million
Q1 2019 May 13, 2019	BUY	$12.79 - $17.62 $15.1 Million - $20.8 Million	1,179,246 Added 17.34%	7,981,198 $136 Million
Q4 2018 Feb 01, 2019	BUY	$11.39 - $27.13 $11.9 Million - $28.4 Million	1,048,162 Added 18.22%	6,801,952 $92.8 Million
Q3 2018 Nov 07, 2018	BUY	$25.78 - $32.6 $32 Million - $40.4 Million	1,240,206 Added 27.48%	5,753,790 $165 Million
Q2 2018 Aug 07, 2018	BUY	$20.02 - $30.79 $18.2 Million - $28 Million	910,608 Added 25.27%	4,513,584 $123 Million
Q1 2018 May 14, 2018	BUY	$19.43 - $34.95 $43.3 Million - $77.9 Million	2,227,827 Added 162.01%	3,602,976 $76 Million
Q4 2017 Feb 12, 2018	BUY	$17.39 - $31.12 $17.4 Million - $31.2 Million	1,002,671 Added 269.19%	1,375,149 $26.4 Million
Q3 2017 Nov 09, 2017	BUY	$15.16 - $25.75 $3 Million - $5.09 Million	197,668 Added 113.08%	372,478 $9.26 Million
Q2 2017 Aug 11, 2017	BUY	N/A	94,960 Added 118.92%	174,810 $2.8 Million
Q1 2017 May 15, 2017	BUY	N/A	53,306 Added 200.82%	79,850 $1.13 Million
Q4 2016 Feb 13, 2017	BUY	N/A	26,544	26,544 $348,000

Others Institutions Holding NTLA

# of Institutions

338

Shares Held

98.3M

Call Options Held

784K

Put Options Held

713K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $899M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track Cathie Wood's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ark Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ark Investment Management LLC and Cathie Wood with notifications on news.

Account